LIVER LOBULE ARCHITECTURE AND FIBROSIS PATTERNS: AN ANATOMICAL AND HISTOPATHOLOGICAL EVALUATION IN CHRONIC LIVER DISEASE

Main Article Content

Dr. Amna Halima
Dr. Sumaira Javed
Dr. Asma Begum
Dr. Aisha Sadaf
Dr. Nadira Hameed
 Dr. Muhammad Tariq

Keywords

chronic liver disease, fibrosis, liver lobule architecture, histopathology, pseudolobule formation, inflammatory infiltration, liver biopsy

Abstract

Objective: Chronic liver disease (CLD) leads to progressive structural changes in the liver, including fibrosis and lobular distortion. This study evaluates the histopathological alterations in liver lobule architecture and fibrosis patterns in CLD patients, correlating these changes with clinical and biochemical markers.


Methods: A cross-sectional study was conducted at Bacha Khan Medical college affiliated with Mardan Medical Complex, Mardan from April 2023 to April 2024, including 84 patients diagnosed with CLD. Demographic details, clinical parameters, and laboratory findings were recorded. Liver biopsies were analyzed to assess fibrosis stage, inflammatory activity, and lobular architectural changes. Fibrosis was graded using the METAVIR scoring system. Statistical analysis was performed to determine associations between fibrosis severity and clinical markers.


Results: The majority of patients were between 30 and 50 years of age, with a higher prevalence in males. Obesity and diabetes showed significant associations with CLD progression. Histopathological evaluation revealed increasing lobular distortion and pseudolobule formation with advancing fibrosis. Inflammatory infiltration was observed in most cases, with periportal inflammation being the most common. Patients with severe fibrosis had significantly elevated ALT, AST, APRI, and FIB-4 scores. Signs of portal hypertension, including splenomegaly and esophageal varices, were more frequent in advanced fibrosis stages.


Conclusion: The study confirms that CLD leads to progressive architectural changes in the liver, which correlate with fibrosis severity. Liver biopsy remains a crucial tool for assessing histopathological patterns and guiding clinical management. Early identification of metabolic risk factors and routine monitoring of biochemical markers can aid in preventing disease progression.

Abstract 197 | pdf Downloads 148

References

1. Kleczka A, Mazur B, Tomaszek K, Dzik R, Kabała-Dzik A. Diagnosis of liver fibrosis using digital analysis. Journal of Laboratory Diagnostics. 2023;59(2):65-72.
2. Hollyer J. Pathologic assessment of equine hepatic disease: University of Glasgow; 2022.
3. Dezső K, Paku S, Kóbori L, Thorgeirsson SS, Nagy P. What Makes Cirrhosis Irreversible?—Consideration on Structural Changes. Frontiers in medicine. 2022;9:876293.
4. Filozof CM, Lackner C, Romero-Gómez M, Imperial JC, McGee R, Dimick-Santos L, et al. Best practices in liver biopsy histologic assessment for nonalcoholic steatohepatitis clinical trials: expert opinion. GastroHep. 2022;2022(1):3538103.
5. Maheswari N, Behera S, Mahapatro A, Ray S. A Prospective Observational Study on the Role of Special Stains in Physiological and Histopathological Study of Liver. Fortune Journal of Health Sciences. 2024;7(2):192-6.
6. Ozdogan E, Arikan C. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy. Clinical and Experimental Pediatrics. 2022;66(3):110.
7. Ugo L, Brocco S, Merola A, Mescoli C, Quaia E. Liver Anatomy. Imaging of the Liver and Intra-hepatic Biliary Tract: Volume 1: Imaging Techniques and Non-tumoral Pathologies. 2021:15-47.
8. Jiao J, Zhang X. Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights. Advances in Anatomic Pathology. 2025:10.1097.
9. Leow W-Q, Chan AW-H, Mendoza PGL, Lo R, Yap K, Kim H. Non-alcoholic fatty liver disease: the pathologist’s perspective. Clinical and Molecular Hepatology. 2022;29(Suppl):S302.
10. Padalino MA, Chemello L, Cavalletto L, Angelini A, Fedrigo M. Prognostic value of liver and spleen stiffness in patients with Fontan Associated Liver Disease (FALD): A Case Series with Histopathologic Comparison. Journal of Cardiovascular Development and Disease. 2021;8(3):30.
11. Sanyal AJ, Jha P, Kleiner DE. Digital pathology for nonalcoholic steatohepatitis assessment. Nature Reviews Gastroenterology & Hepatology. 2024;21(1):57-69.
12. Giashuddin S, Alawad M. Histopathological diagnosis of nonalcoholic steatohepatitis (NASH). Non-Alcoholic Steatohepatitis: Methods and Protocols: Springer; 2022. p. 1-18.
13. Somnay K, Wadgaonkar P, Sridhar N, Roshni P, Rao N, Wadgaonkar R. Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives. Biomedicines. 2024;12(10):2229.
14. Geier A, Tiniakos D, Denk H, Trauner M. From the origin of NASH to the future of metabolic fatty liver disease. Gut. 2021;70(8):1570-9.
15. Barr RG. Conventional ultrasound findings in chronic liver disease. Multiparametric ultrasound for the assessment of diffuse liver disease: a practical approach Philadelphia, PA: Elsevier. 2022:7-24.
16. Baloda V, Anand A, Yadav R, Mehra L, Rajeshwari M, Vishnubhatla S, et al. Histologic changes in core-needle liver biopsies from patients with acute-on-chronic liver failure and independent histologic predictors of 28-day mortality. Archives of Pathology & Laboratory Medicine. 2022;146(7):846-54.
17. Barr RG. Multiparametric Ultrasound for Chronic Liver Disease. Radiologic Clinics. 2025;63(1):13-28.
18. Meroueh C, Warasnhe K, Tizhoosh HR, Shah VH, Ibrahim SH. Digital pathology and spatial omics in steatohepatitis: Clinical applications and discovery potentials. Hepatology. 2024:10.1097.
19. Dana J, Debray D, Beaufrère A, Hillaire S, Fabre M, Reinhold C, et al. Cystic fibrosis-related liver disease: clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies. Journal of Hepatology. 2022;76(2):420-34.
20. Rubino JG, Nasirzadeh AR, van der Pol CB, Dhindsa K, Chung AD. Quantitative and qualitative liver CT: imaging feature association with histopathologically confirmed hepatic cirrhosis. Abdominal Radiology. 2022;47(7):2314-24.
21. Hudson D, Afzaal T, Bualbanat H, AlRamdan R, Howarth N, Parthasarathy P, et al. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Therapeutic Advances in Gastroenterology. 2024;17:17562848241276334.